This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Georgia Tech Research Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Athena Patterson-Orazem: Innovator in Myocilin Research
Introduction
Athena Patterson-Orazem is a distinguished inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biomedical research, particularly in the study of myocilin, a protein associated with glaucoma.
Latest Patents
Athena holds a patent for "Antibodies that bind to natively folded myocilin." This patent includes myocilin-binding agents, such as antibodies and antigen-binding fragments, as well as fusion proteins that specifically bind to the coiled-coil domain of myocilin. Importantly, these agents do not bind to misfolded myocilin. The disclosed antibodies and antigen-binding fragments are useful for the detection and extraction of natively folded myocilin from various samples.
Career Highlights
Athena is currently affiliated with the Georgia Tech Research Corporation, where she continues her innovative work in the field. Her research has the potential to impact the understanding and treatment of glaucoma, a leading cause of blindness worldwide.
Collaborations
Athena collaborates with notable colleagues, including Raquel L. Lieberman and Shannon E. Hill, who contribute to her research endeavors.
Conclusion
Athena Patterson-Orazem is a pioneering inventor whose work on myocilin-binding agents is paving the way for advancements in glaucoma research. Her contributions are vital to the ongoing exploration of this important protein and its implications for eye health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile